Sukran Ozturk | Pharmaceutical Sciences | Women Researcher Award

Posted on by The Scientist

Assoc. Prof. Dr. Sukran Ozturk | Pharmaceutical Sciences | Women Researcher Award

Faculty of Pharmacy | Zonguldak Bulent Ecevit University | Turkey

Assoc. Prof. Dr. Şükran Öztürk is an Assistant Professor specializing in microbiology, with a strong research focus on antimicrobial resistance, antifungal and antibacterial agents, natural bioactive compounds, and in vivo infection models, particularly Galleria mellonella. She has authored 30+ peer-reviewed publications, accumulating 150 citations, with an h-index of 7 and i10-index of 6. Her work has appeared in reputable international journals such as Molecules, Microbial Pathogenesis, Archives of Microbiology, and Future Microbiology. She has led and collaborated on multidisciplinary studies exploring essential oils, peptides, phage therapy, and synergistic antimicrobial strategies against multidrug-resistant pathogens. Her research contributes to global efforts in combating antimicrobial resistance and advancing alternative therapeutic approaches with potential clinical and societal impact.

Citation Metrics (Google Scholar)

150
100
50
0

Citations

150

h-index

7

i10-index

6

Citations

h-index

i10-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Yanan Yang | Pharmaceutical Sciences | Research Excellence Award

Posted on by The Scientist

Ms. Yanan Yang | Pharmaceutical Sciences | Research Excellence Award

Student | Tianjin University of Traditional Chinese Medicine | China

Dr. Yanan Yang is a researcher at Tianjin University of Traditional Chinese Medicine, recognized for her contributions at the intersection of gut microbiota, metabolic regulation, and cardiometabolic diseases. Her scholarly influence is demonstrated by 726 citations, 45 peer-reviewed publications, and an h-index of 14, underscoring her growing impact in biomedical and translational health research. Dr. Yang’s work spans gut microbiome dynamics, microbial metabolites, metabolic disorders, traditional Chinese medicine mechanisms, and multi-omics integration. She has contributed to high-visibility studies on acute coronary syndrome, cardiovascular disease mechanisms, type 2 diabetes regulation, and herbal-medicine-induced metabolic modulation. Her involvement in multi-center collaborations—including meta-analyses with large participant cohorts—reflects her ability to bridge clinical findings with microbiome-mediated insights. Dr. Yang’s publications highlight a consistent focus on understanding microbial signatures, therapeutic pathways, and host–microbe interactions to advance preventive and precision medicine. She has also engaged in studies evaluating herbal interventions such as Coptis chinensis, showcasing the integration of traditional medicine with modern biomedical evidence. With over 223 co-authors across her publication record, her collaborative networks extend nationally and internationally, supporting multidisciplinary innovation in gut–heart metabolic axis research. Dr. Yang’s ongoing contributions provide essential foundations for developing microbiome-based diagnostics, therapeutic strategies for metabolic diseases, and evidence-based applications of traditional Chinese medicine, reflecting her role as an emerging and influential scientist in her field.

Featured Publications

  1. Wu, C., Zhao, Y., Zhang, Y., Yang, Y., Su, W., Yang, Y., Sun, L., Zhang, F., Yu, J., … (2022). Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates prediction of BBR’s cholesterol-lowering efficacy in patients. Journal of Advanced Research, 37, 197–208. Cited by: 78

  2. Dong, C., Yang, Y., Wang, Y., Hu, X., Wang, Q., Gao, F., Sun, S., Liu, Q., Li, L., Liu, J., … (2023). Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction compared with stable coronary artery disease. Journal of Advanced Research, 46, 101–112. Cited by: 74

  3. Dong, C., Yu, J., Yang, Y., Zhang, F., Su, W., Fan, Q., Wu, C., & Wu, S. (2021). Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion. Biomedicine & Pharmacotherapy, 139, 111595. Cited by: 74

  4. Yang, Y. N., Wang, Q. C., Xu, W., Yu, J., Zhang, H., & Wu, C. (2022). The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet-induced hyperlipidemia and stimulates liver LDLR expression. Biomedicine & Pharmacotherapy, 155, 113749. Cited by: 60

  5. Xu, W., Yu, J., Yang, Y., Li, Z., Zhang, Y., Zhang, F., Wang, Q., Xie, Y., Zhao, B., & Wu, C. (2023). Strain-level screening of human gut microbes identifies Blautia producta as a new anti-hyperlipidemic probiotic. Gut Microbes, 15(1), 2228045. Cited by: 57

Jan Radford | Pharmaceutical Sciences | Best Researcher Award

Posted on by The Scientist

Prof. Jan Radford | Pharmaceutical Sciences | Best Researcher Award

Prof in General Practice | University of Tasmania | Australia

Professor Jan Radford is a distinguished academic in general practice and medical education, currently based at the Tasmanian School of Medicine, University of Tasmania. With over three decades of professional and academic experience, she has contributed extensively to curriculum design, health professional education, and research capacity building within primary care. She has authored 59 peer-reviewed publications, which have collectively received over 535 citations, reflecting her sustained influence in the field. Professor Radford’s scholarly and leadership contributions span undergraduate, postgraduate, and vocational levels of medical education. As a long-serving faculty member, she has played a pivotal role in shaping the University of Tasmania’s medical curriculum, particularly through initiatives such as the development of innovative rural and aged care placements. Her leadership as Director of the Launceston Clinical School (2022–2024) further strengthened community-based clinical education and interprofessional collaboration across Tasmania. Nationally, she has held major roles in the Royal Australian College of General Practitioners (RACGP), notably serving as Censor-in-Chief, where she oversaw educational quality assurance, specialty recognition, and the advancement of Indigenous health education. Her work in developing the GP MAGIC framework and establishing Tasmania’s practice-based research network has fostered practitioner-led inquiry and evidence-informed primary care. A 2017 Churchill Fellow, Professor Radford investigated the use of routinely collected general practice electronic health data to enhance patient outcomes. This aligns with her ongoing research focus on integrating e-health data, clinical audit, and educational innovation to improve general practice systems and learning environments. Through her extensive collaborations and commitment to translating research into practice, Professor Radford continues to influence healthcare education and delivery in Australia and beyond, contributing meaningfully to the advancement of community-oriented, data-informed primary care.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., Brett, T., Radford, J., et al. (2021). Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia. Heart, Lung and Circulation, 30(3), 324–349. https://doi.org/10.1016/j.hlc.2020.10.013 — 108 citations

  2. Fan, S., Radford, J., & Fabian, D. (2016). A mixed-method research to investigate the adoption of mobile devices and Web 2.0 technologies among medical students and educators. BMC Medical Informatics and Decision Making, 16(1), 43. https://doi.org/10.1186/s12911-016-0282-4 — 52 citations

  3. Bezabhe, W. M., Bereznicki, L. R., Radford, J., Wimmer, B. C., Salahudeen, M. S., et al. (2022). Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: A population-based cohort study. Journal of the American Heart Association, 11(7), e023098. https://doi.org/10.1161/JAHA.121.023098 — 46 citations

  4. Castelino, R. L., Saunder, T., Kitsos, A., Peterson, G. M., Jose, M., Wimmer, B., Radford, J., et al. (2020). Quality use of medicines in patients with chronic kidney disease. BMC Nephrology, 21(1), 216. https://doi.org/10.1186/s12882-020-01849-7 — 37 citations

  5. Bezabhe, W. M., Bereznicki, L. R., Radford, J., Wimmer, B. C., & Curtain, C. (2021). Ten-year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation. Frontiers in Pharmacology, 12, 586370. https://doi.org/10.3389/fphar.2021.586370 — 36 citations